» Articles » PMID: 35692981

Exome Sequencing Identifies the Extremely Rare and Variants in Early Onset Inflammatory Bowel Disease Patients

Abstract

Background: Molecular diagnosis of early onset inflammatory bowel disease (IBD) is very important for adopting suitable treatment strategies. Owing to the sparse data available, this study aims to identify the molecular basis of early onset IBD in Arab patients.

Methods: A consanguineous Arab family with monozygotic twins presenting early onset IBD was screened by whole exome sequencing (WES). The variants functional characterization was performed by a series of computational biology methods. The IBD variants were further screened in whole exome data of 100 Saudi cohorts ensure their rare prevalence in the population.

Results: Genetic screening has identified the digenic autosomal recessive mode of inheritance of (G58V) and (G313V) variants in IBD twins with early onset IBD. Findings from pathogenicity predictions, stability and molecular dynamics have confirmed the deleterious nature of both variants on structural features of the corresponding proteins. Functional biology data suggested that both genes show abundant expression in gastrointestinal tract and immune organs, involved in immune cell restriction, regulation of different immune related pathways. Data from knockout mouse models for gene has revealed that the dysregulated expression of this gene impacts intestinal immune homeostasis. The defective and involved in integrin pathway, are likely to induce intestinal inflammation by disturbing immune homeostasis.

Conclusions: Our findings provide novel insights into the molecular etiology of pediatric onset IBD and may likely pave way in developing genomic medicine.

Citing Articles

High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia.

Aljohani H, Anbarserry D, Mosli M, Ujaimi A, Bakhshwin D, Elango R Biomedicines. 2025; 13(2).

PMID: 40002872 PMC: 11852680. DOI: 10.3390/biomedicines13020459.


Gene expression analysis reveals mir-29 as a linker regulatory molecule among rheumatoid arthritis, inflammatory bowel disease, and dementia: Insights from systems biology approach.

S D, Sundararajan V PLoS One. 2025; 20(1):e0316584.

PMID: 39813219 PMC: 11734936. DOI: 10.1371/journal.pone.0316584.


Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach.

Alfonso Perez G, Castillo R Medicina (Kaunas). 2023; 59(7).

PMID: 37512030 PMC: 10383667. DOI: 10.3390/medicina59071218.


Rare variant burden analysis from exomes of three consanguineous families reveals and as potential key proteins in inflammatory bowel disease pathogenesis.

Jan R, Al-Numan H, Al-Twaty N, Alrayes N, Alsufyani H, Alaifan M Front Med (Lausanne). 2023; 10:1164305.

PMID: 37215724 PMC: 10196255. DOI: 10.3389/fmed.2023.1164305.


Structural Protein Effects Underpinning Cognitive Developmental Delay of the p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics Framework.

Lopez-Rivera J, Rodriguez-Salazar L, Soto-Ospina A, Estrada-Serrato C, Serrano D, Chaparro-Solano H Brain Sci. 2022; 12(7).

PMID: 35884678 PMC: 9313109. DOI: 10.3390/brainsci12070871.

References
1.
Laskowski R, Thornton J . PDBsum extras: SARS-CoV-2 and AlphaFold models. Protein Sci. 2021; 31(1):283-289. PMC: 8662102. DOI: 10.1002/pro.4238. View

2.
Frolkis A, Dieleman L, Barkema H, Panaccione R, Ghosh S, Fedorak R . Environment and the inflammatory bowel diseases. Can J Gastroenterol. 2013; 27(3):e18-24. PMC: 3732155. DOI: 10.1155/2013/102859. View

3.
El Mouzan M, AlEdreesi M, Hasosah M, Al-Hussaini A, Al Sarkhy A, Assiri A . Regional variation of pediatric inflammatory bowel disease in Saudi Arabia: Results from a multicenter study. World J Gastroenterol. 2020; 26(4):416-423. PMC: 7002901. DOI: 10.3748/wjg.v26.i4.416. View

4.
Ouahed J, Spencer E, Kotlarz D, Shouval D, Kowalik M, Peng K . Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis. 2019; 26(6):820-842. PMC: 7216773. DOI: 10.1093/ibd/izz259. View

5.
Husby S, Koletzko S, Korponay-Szabo I, Mearin M, Phillips A, Shamir R . European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2011; 54(1):136-60. DOI: 10.1097/MPG.0b013e31821a23d0. View